Page last updated: 2024-08-18

syringaldehyde and ER-Negative PR-Negative HER2-Negative Breast Cancer

syringaldehyde has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jin, XX; Liang, G; Mei, YN; Shen, Z; Xing, SH; Yang, HM; Zheng, XH; Zhu, JF	1

Other Studies

1 other study(ies) available for syringaldehyde and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 101 Topics: Apoptosis; Benzaldehydes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Chalcones; Cytoskeletal Proteins; Cytoskeleton; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Recurrence, Local; Phosphorylation; STAT3 Transcription Factor; Triple Negative Breast Neoplasms	2022

Article

Year

A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 101

Topics: Apoptosis; Benzaldehydes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Chalcones; Cytoskeletal Proteins; Cytoskeleton; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Recurrence, Local; Phosphorylation; STAT3 Transcription Factor; Triple Negative Breast Neoplasms

2022